Singapore, March 26 -- Xcell Biosciences Australia Pty Ltd, an Australian affiliate of the San Francisco-based instrumentation company focused on cell and gene therapy applications, has entered into an agreement with the Royal Perth Hospital to use its AVATAR Foundry platform in a clinical trial focused on rapid manufacturing of more potent cancer-killing cell therapies.

Planet Innovation, an Australian headquartered medtech innovation company, is Xcellbio's contract development and manufacturing partner. The company has worked with Xcellbio during the past 2 years to develop the AVATAR Foundry instrument from its innovation headquarters in Melbourne. Planet Innovation will support Xcellbio with additional on-the-ground technical support...